Ketamine Clinical Trial
— KetCatOfficial title:
The Application of Ketamine for Sedation in Patients With Cardiac Arrest: Feasibility, Safety, and Potential Impact on Neurological Outcomes
Recent evidence suggests ketamine may attenuate harmful cellular cascades taking place after brain injury that result in permanent damage. The investigators are interested in researching the application of this in the setting of cardiac arrest. Following cardiac arrest, the brain is deprived oxygen for a period of time, leading to the imitation of these harmful cellular processes. The investigators hypothesize that patients who receive ketamine as part of their standard sedation procedures during cardiac arrest treatment have better neurological functioning compared to those who do not.
Status | Recruiting |
Enrollment | 24 |
Est. completion date | December 12, 2023 |
Est. primary completion date | December 9, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - All out-of-hospital cardiac arrests (OHCA) with a "shockable rhythm" (ventricular fibrillation, pulseless ventricular tachycardia) that present to the Royal Columbian Hospital. The patient may be either in active cardiac arrest with shockable rhythm or may have achieved Return of Spontaneous Circulation (ROSC). - Over 19 years of age - Patients requiring sedation based on the assessment of the resuscitating physician. Exclusion Criteria: - Any other type of cardiac arrest - Any history of previous, pre-existing neurological deficit - Started on Extracorporeal Membrane Oxygenation (ECMO) - Duration of cardiac arrest without ROSC is greater than 30 consecutive minutes - Known contraindication or hypersensitivity to ketamine - Awake patient or no standard sedation or no intubation required - Inability to obtain deferred consent - Currently enrolled in any other research study involving drugs or devices - Patients who are pregnant - Patients who are prisoners - Patients residing in Long Term Care (LTC) facilities |
Country | Name | City | State |
---|---|---|---|
Canada | Fraser Health Authority - Royal Columbian Hospital | New Westminster | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Fraser Health |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility Data | To test the appropriateness of the eligibility criteria by recording enrolment rates of eligible patients, test the randomization assignment procedures by evaluating for any difference in baseline characteristics between groups, and test adequate adherence to protocol by recording time taken to administer intervention during sedation procedures. | through study completion, an average of 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03781817 -
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
|
Phase 4 | |
Completed |
NCT04199468 -
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
|
Phase 1 | |
Recruiting |
NCT03272698 -
ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression
|
Phase 4 | |
Completed |
NCT02987985 -
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
|
Phase 3 | |
Recruiting |
NCT05089526 -
Opioid-free Anesthesia in Laparoscopic Cholecystectomies
|
N/A | |
Completed |
NCT06243822 -
Ketamine Versus Propofol as ICU Sedation
|
Phase 4 | |
Completed |
NCT04022226 -
EEG Characteristics in ECT
|
Early Phase 1 | |
Completed |
NCT03336541 -
Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
|
Phase 4 | |
Recruiting |
NCT04622904 -
Lidocaine and Magnesium and Ketamine in Gynecological Surgery
|
N/A | |
Recruiting |
NCT05717361 -
Opioid Sparing Anesthesia in Cervical Spine Surgery
|
N/A | |
Completed |
NCT03375671 -
Rapid Agitation Control With Ketamine in the Emergency Department
|
Phase 2 | |
Recruiting |
NCT02717052 -
Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
|
Phase 2 | |
Recruiting |
NCT05837000 -
Dexmedetomidine, Ketamine and Magnesium Sulphate in Caudal Block for Hypospadias Repair
|
Phase 4 | |
Recruiting |
NCT04144933 -
Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery
|
Phase 3 | |
Recruiting |
NCT06431178 -
General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients
|
N/A | |
Recruiting |
NCT05243940 -
Opioid-free Anesthesia in Thyroidectomies
|
N/A | |
Completed |
NCT05288764 -
Effect of Ketamine on BIS Values
|
||
Recruiting |
NCT06331182 -
Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain
|
N/A | |
Completed |
NCT03231683 -
Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy
|
Phase 2 | |
Recruiting |
NCT05256264 -
Machine-learning Algorithm to Differentiate Intraoperative Ketamine Dosing Based on Electroencephalographic Density Spectrum Array Analysis
|